Barriers surround access to MPOX vaccine: 5 things you need to know

As smallpox cases rise worldwide, many Americans at high risk of contracting the virus are struggling to access the Jynneos vaccine due to its high cost and gaps in insurance coverage. New York Times reported on November 4.

Here are five things you need to know:

1. While the vaccine was once available for free through federal programs, it is now sold commercially for nearly $300 per dose, creating barriers for the uninsured and vulnerable populations.
2. Insurance companies do not yet cover the cost of the vaccine or only reimburse a small portion of its cost; this could leave many without access. People in high-risk groups, such as gay and bisexual men and people living with HIV, may be particularly affected.
3. Research has shown that people living with HIV are more vulnerable to severe cases of mpox. However, even with increased risk, they face difficulties accessing the vaccine. Many HIV-positive people are uninsured or have difficulty obtaining coverage, putting them at higher risk, according to the report.
4. Some doses from the federal stockpile were sent to health centers for the uninsured, but they expired Oct. 31, leaving many with no choice.
5. Public health officials and advocates are concerned that the lack of available vaccines could lead to a larger outbreak in the United States, according to the Department of Health. Time. The CDC continues to recommend the vaccine for people at risk.